Mainstream Medical Treatment
After the diagnosis of diabetes, modern mainstream medical treatment consists of either oral hypoglycemic agents or insulin.
• Oral hypoglycemic agents In 1955, oral hypoglycemic drugs were introduced. Currently available oral hypoglycemic agents fall into five classifications according to their biophysical mode of action. These classes are: biguanides; glucosidase inhibitors; meglitinides; sulphonylureas; and thiazolidinediones.
The biguanides lower blood sugar in three ways. They inhibit the liver’ s normal release of its glucose stores, they interfere with intestinal absorption of glucose from ingested carbohydrates, and they are said to increase peripheral uptake of glucose.
The glucosidase inhibitors are designed to inhibit the amylase enzymes produced by the pancreas and which are essential to the digestion of carbohydrates. The theory is that if the digestion of carbohydrates is inhibited, the blood sugar level cannot be elevated.
==================== end of chapter preview ====================
• Insulin Today, insulin is prescribed for both the Type I and Type II diabetics. Injectable insulin substitutes for the insulin that the body no longer produces. Of course, this treatment, while necessary for preserving the life of the Type I diabetic, is highly questionable when applied to the Type II diabetic.
It is important to note that neither insulin nor any of these oral hypoglycemic agents exerts any curative action whatsoever on any type of diabetes. None of these medical strategies is designed to normalize the cellular uptake of glucose by the cells that need it to power their activity.
The prognosis with these " modern " mainstream treatments is increasing disability and early death from heart or kidney failure or the failure of some other vital organ.
www. theictm. org
Preview- 7 Steps to Health and the Big Diabetes Lie